These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Not Available]. Sorrel Dejerine A; Do Rosario G; Caplier A; Pépin M; Cudennec T Soins Gerontol; 2016; (118):45-6. PubMed ID: 26976320 [No Abstract] [Full Text] [Related]
5. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial. Roth AS; Ostroff RB; Hoffman RE J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558 [TBL] [Abstract][Full Text] [Related]
6. Naltrexone as a treatment of self-injurious behavior: a case report. Griengl H; Dantendorfer K Eur Psychiatry; 2001 Apr; 16(3):193-4. PubMed ID: 11353600 [No Abstract] [Full Text] [Related]
7. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders]. Bolm T; Piegler T Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827 [TBL] [Abstract][Full Text] [Related]
8. Benztropine for venlafaxine-induced night sweats. Pierre JM; Guze BH J Clin Psychopharmacol; 2000 Apr; 20(2):269. PubMed ID: 10770471 [No Abstract] [Full Text] [Related]
9. Naltrexone treatment of self-injurious thoughts and behaviors. Sonne S; Rubey R; Brady K; Malcolm R; Morris T J Nerv Ment Dis; 1996 Mar; 184(3):192-5. PubMed ID: 8600226 [No Abstract] [Full Text] [Related]
10. Venlafaxine-associated hyponatremia presenting with catatonia. Grover S; Somaiya M; Ghormode D J Neuropsychiatry Clin Neurosci; 2013; 25(2):E11-2. PubMed ID: 23686044 [No Abstract] [Full Text] [Related]
11. Venlafaxine in the treatment of borderline personality disorder. Markovitz PJ; Wagner SC Psychopharmacol Bull; 1995; 31(4):773-7. PubMed ID: 8851652 [TBL] [Abstract][Full Text] [Related]
12. Naltrexone as a treatment of self-injurious behavior--a case report. Griengl H; Sendera A; Dantendorfer K Acta Psychiatr Scand; 2001 Mar; 103(3):234-6. PubMed ID: 11240582 [TBL] [Abstract][Full Text] [Related]
13. Venlafaxine-induced reset osmostat syndrome: case of a 79-year-old depressed woman. Ranieri P; Franzoni S; Rozzini R; Trabucchi M J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):75-8. PubMed ID: 9188023 [TBL] [Abstract][Full Text] [Related]
14. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. Pittenger C; Krystal JH; Coric V J Clin Psychiatry; 2005 Nov; 66(11):1492-3. PubMed ID: 16420092 [No Abstract] [Full Text] [Related]
15. A case of venlafaxine-induced kleptomania. Demartini B; D'Agostino A; Basi C; Gambini O Eur J Clin Pharmacol; 2016 Apr; 72(4):509-10. PubMed ID: 26706250 [No Abstract] [Full Text] [Related]
16. Naltrexone treatment for a 3-year-old boy with self-injurious behavior. White T; Schultz SK Am J Psychiatry; 2000 Oct; 157(10):1574-82. PubMed ID: 11007709 [No Abstract] [Full Text] [Related]
17. Long-term effects of naltrexone on self-injurious behavior. Sandman CA; Hetrick W; Taylor DV; Marion SD; Touchette P; Barron JL; Martinezzi V; Steinberg RM; Crinella FM Am J Ment Retard; 2000 Mar; 105(2):103-17. PubMed ID: 10755174 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of dissociative symptoms in borderline patients with naltrexone]. Schmahl C; Stiglmayr C; Böhme R; Bohus M Nervenarzt; 1999 Mar; 70(3):262-4. PubMed ID: 10231814 [TBL] [Abstract][Full Text] [Related]